{
  "node_id": "us-fda-cfr-21-part-11-electronic-records-signatures",
  "title": "21 CFR Part 11 - Electronic Records; Electronic Signatures",
  "domain": "Pharmaceuticals & Life Sciences",
  "version": "1.0.0",
  "last_updated": "2026-05-06",
  "bluf": "This regulation establishes the criteria under which the U.S. Food and Drug Administration considers electronic records, electronic signatures, and…",
  "paywall": {
    "status": "LOCKED",
    "unlock_cost_usd": "0.01",
    "skyfire_id": "41779894-ece2-4163-9761-b3b1b76e19b0"
  },
  "crosswalks": {
    "_available_keys": [
      "nist_framework",
      "iso_standard",
      "industry_mapping",
      "ai_overlay_2026"
    ],
    "_note": "Full crosswalk values included in vault response"
  },
  "primary_citations_count": 7,
  "workflow_steps_count": 8,
  "schema_fields_count": 8,
  "citation_preview": [
    "§ 11.10 Controls for closed systems.",
    "§ 11.30 Controls for open systems."
  ]
}